SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Northfield Lab(NFLD)
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
148 20 0 NFLD
Emcee:  BKS Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
73 Volume and price up on no news. earnings report will be out soon, there will berbob-7/15/1998
72 erbob, nice to get your input. Biopure's trying to do an end run with HemopMerritt-7/12/1998
71 i'm new to this board but write frequently on nfld board at yahoo. I'verbob-7/12/1998
70 V1, it looks that way to me, also...at least for now. In 2 or 3 years we may haMerritt-7/8/1998
69 Merrit, Thanks for the info and followup due dilligence. It looks like Biopure Vector1-7/8/1998
68 V1: I just talked with Doug Sayles, Assoc. Director of Marketing at Biopure, niMerritt-7/8/1998
67 Merrit, I have no problem with disagreement. The following is from a SeptemberVector1-7/7/1998
66 You raise some good points. NFLD started enrollment for Phase III in Sept. of &Merritt-7/7/1998
65 NFLD has no chance of a product launch in 99. They have not finished their phaVector1-7/7/1998
64 Vector 1: Biopure's web site says, "...market introduction of HemopureMerritt-7/7/1998
63 I still like NFLD better. borb-6/25/1998
62 Better take a look at biopure.com V1 Vector1-6/22/1998
61 NFLD is in phase 3. The maximum volume they have achieved was equivalent to comborb-6/22/1998
60 <<<<I believe NFLD is at leading position. explain your answer fchirodoc-6/22/1998
59 I believe NFLD is at leading position. borb-6/22/1998
58 there are other blood substitutes besides nfld.....sgnc for example as well as chirodoc-6/20/1998
57 The stock is at 52 weeks high and going up. I wonder why none notice this boardborb-5/11/1998
56 NFLD is really an investment stock and a R&D technically strong stock. I haborb-4/28/1998
55 Unlike NFLD focuses on blood substitute, ALLP is a pharmaceutical research and borb-4/21/1998
54 What about Alliance (ALLP)? Aren't they a competitor with Oxygent?Miguel M. de la O-4/21/1998
53 Good to see you back. The only potential competitor, SMTG, was purchased by Baxborb-4/21/1998
52 Hi all, been a while for me on this thread. Back in at 11.75. I'm not surDoug Schneider-4/20/1998
51 The present price of NFLD is still very very low compare with a couple years agborb-4/3/1998
50 Indeed, NFLD stands alone, and biased or not, the mangement has no hesitation iOrwell-4/2/1998
49 Obviously, when Baxter having problem, NFLD is the only one leading in this indborb-4/2/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News